Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Pipeline / planning |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Planned |
| Estimated Value (ex. VAT): | £6,200,000 |
| Estimated Value (inc. VAT): | £7,440,000 |
| Release Date: | 23 April 2026 |
| Application Deadline: | — |
| Contract Start Date: | 30 June 2027 (Estimated) |
| Contract End Date: | 30 June 2028 (Estimated) |
| Contract Duration: | 1.0 years |
| Procurement ID (OCID): | ocds-h6vhtk-06891e |
| Notice Reference: | 036864-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Project title: NHS National Framework for Emtricitabine/Rilpivirine/Tenofovir Alafenamide 200 mg/25 mg/25 mg Odefsey or eqv. Offer reference number: CM/TNS/26/5753 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net
Published contracts in the last 12 months
1,931
total contracts
£83833.9m
total value
£106,931,015
average contract size
Typical categories
Pipeline status
Not addedContract imported automatically · AI writes the response
Estimated Value
£6,200,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →